Angiotensin converting enzyme inhibition corrects Na+/H+ exchanger overactivity in essential hypertension

American Journal of Hypertension

Volumn 10, Issue 1, 1997, Pages 84-93

  Fortuño, Antonia ^a   Tisaire, Javier ^b   López, Rafael ^a   Bueno, José ^b   Díez, Javier ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

angiotensin converting enzyme; hypertension; lymphocytes; Na+ H+ exchanger

Indexed keywords

QUINAPRIL;

ARTICLE; CELL PH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; ORAL DRUG ADMINISTRATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; HUMANS; HYPERTENSION; ISOQUINOLINES; LYMPHOCYTES; MALE; MIDDLE AGED; RNA, MESSENGER; SODIUM-HYDROGEN ANTIPORTER; TETRAHYDROISOQUINOLINES;

EID: 0031032508     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(96)00296-8     Document Type: Article

References (39)

1. Canessa M, Morgan K, Godszer R, et al. Kinetic abnormalities of the red blood cell sodium-proton exchange in hypertensive patients. Hypertension. 17:1991;340-348.
2. + antiport in essential hypertension. J Hypertens. 8:1990;533-537.
3. + exchanger is stimulated and cell volume increased in lymphocytes from patients with essential hypertension. J Hypertens. 9:1991;519-524.
4. + exchange activity in normotensive and hypertensive subjects: effect of enalapril therapy upon antiport activity. J Hypertens. 10:1992;839-847.
5. + antiport activity detected by phosphorus nuclear magnetic resonance spectroscopy in exercising skeletal muscle of patients with essential hypertension. Clin Sci. 79:1990;491-497.
6. Falkner B, Canessa M, Anzalone D. Effect of angiotensin converting enzyme inhibitor (lisinopril) on insulin sensitivity and sodium transport in mild hypertension. 8:1995;454-460.
7. Siffert W, Düsing R. Sodium-proton exchange and primary hypertension. An update. Hypertension. 26:1995;649-655.
8. + exchanger activity and NHE-1 mRNA expression in lymphocytes from patients with essential hypertension. Hypertension. 25:1995;356-364.
9. Rosskopf D, Frömter E, Siffert W. Hypertensive sodium-proton exchanger phenotype persists in immortalized lymphoblasts from essential hypertensive patients: a cell culture model for human hypertension. J Clin Invest. 92:1993;2553-2559.
10. Blumenfeld JD, Mann SJ, Laragh JH. Clinical evaluation and differential diagnosis of the individual hypertensive patient. Laragh JH, Brenner BM. Hypertension: Pathophysiolgy, Diagnosis and Management. 2nd :1995;1897-1912 Raven Press, New York.
11. 2+ in lymphocytes. J Cell Biol. 95:1979;189-196.
12. Thomas JA, Buchbaum RN, Zimnik K, et al. Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ. Biochemistry. 18:1979;2210-2218.
13. Roos A, Boron WF. Intracellular pH. Physiol Rev. 61:1981;296-334.
14. + exchanger. Clin Sci. 79:1990;531-536.
15. + retention in patients with essential hypertension. 8:1995;124-132.
16. Alonso A, Arrázola A, Garciandía A, et al. Erythrocyte anion exchanger and intracellular pH in essential hypertension. Hypertension. 22:1993;348-356.
17. Chomczysky P, Sacchi N. Single-step RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
18. + antiporter cDNAs from human tissues. Am J Physiol. 262:1992;C1069-C1076.
19. Ng SY, Grunning P, Eddy H, et al. Evolution of the functional beta-actin gene and its multipseudogene family: conservation of noncoding and chromosomal dispersion of pseudogenes. Mol Cell Biol. 5:1985;2720-2732.
20. Sealey JE, Gary DJ, Laragh JH. Interpretation and guidelines for the use of plasma and urine aldosterone and plasma angiotensin II, angiotensinogen, prorenin, peripheral and renal vein test. Laragh JH, Brenner BM. Hypertension: Pathophysiology, Diagnosis and Management. 2nd :1995;1156-1168 Raven Press, New York.
21. + exchange in spontaneously hypertensive rats. Hypertension. 9:1987;282-288.
22. Tokudome G, Tomonari H, Gardner JP, et al. Variations in the apparent set point for activation of platelet Na-H antiport. Hypertension. 16:1990;180-189.
23. + exchange in human lymphocytes and platelets in chronic and subacute metabolic acidosis. J Clin Invest. 92:1993;858-865.
24. + antiport: activation in primary hypertension and during chronic NaCl-loading. Eur J Clin Invest. 24:1994;529-539.
25. Carr P, Taub NA, Watta GF, et al. Human lymphocyte sodium-hydrogen exchange: the influence of lipids, membrane fluidity, and insulin. Hypertension. 21:1993;344-352.
26. + exchange decreases the affinity of sodium sites. Kidney Int. 46:1994;365-375.
27. Wehling M, Käsmayr J, Theisen K. Rapid effects of mineralocorticoids on sodium-proton exchanger: genomic or nongenomic pathway. Am J Physiol. 260:1991;E719-E726.
28. + exchanger antiporter phenotype, abundance, and phosphorylation of immortalized lymphoblasts from humans with hypertension. Hypertension. 25:1995;971-977.
29. Siffert W, Rosskopf D, Moritz A. Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension. J Clin Invest. 96:1995;759-766.
30. Bottari SP, de Gasparo M, Steekelings UM, et al. Angiotensin II receptor subtypes: characterization, signalling mechanisms and possible physiological implications. Front Neuroendocrinol. 14:1993;123-171.
31. 2+ concentrations in essential hypertension. Hypertension. 22:1993;853-862.
32. Shimada K, Yazaki Y. Binding sites for angiotensin II in human mononuclear leucocytes. J Biochem. 84:1978;1013-1015.
33. 125I-Angiotensin II binding to human blood cells. J Hypertens. 3:1985;131-137.
34. Shibata H, Suzuki H, Murakami M, et al. Angiotensin II type 1 receptor messenger mRNA levels in human blood cells of patients with primary and secondary hypertension: reference to renin profile. J Hypertens. 12:1994;1275-1284.
35. Suzuki H, Shibata H, Murakami M, et al. Modulation of angiotensin II type 1 receptor mRNA expression in human blood cells: comparison of platelets and mononuclear leucocytes. Endocr J. 42:1995;15-22.
36. Grinstein S, Dixon J. Ion transport, membrane potential and cytoplasmic pH in lymphocytes: changes during activation. Physiol Rev. 69:1989;417-481.
37. Xu MLX. Do immune system changes have a role in hypertension? J Hypertens. 13:1995;1259-1265.
38. Olsen F, Rasmussen S. Delayed hypersensitivity directed against arterial antigens in the hypertensive disease in man. Acta Pathol Microbiol Scand. 81:1973;498-500.
39. Lefkos N, Boura P, Boudonas E, et al. Immunopathogenic mechanisms in hypertension. 8:1995;1141-1145.